Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Processa Pharmaceuticals Inc (NASDAQ: PCSA) was $0.86 for the day, down -9.04% from the previous closing price of $0.95. In other words, the price has decreased by -$9.04 from its previous closing price. On the day, 0.14 million shares were traded. PCSA stock price reached its highest trading level at $0.93 during the session, while it also had its lowest trading level at $0.82.
Ratios:
Our analysis of PCSA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.97 and its Current Ratio is at 3.97. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 25, 2024, initiated with a Buy rating and assigned the stock a target price of $8.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 07 ’24 when Young David bought 21,000 shares for $2.45 per share. The transaction valued at 51,526 led to the insider holds 79,387 shares of the business.
Young David bought 20,000 shares of PCSA for $50,504 on Feb 06 ’24. The Pres. Research & Development now owns 58,387 shares after completing the transaction at $2.53 per share. On Jan 31 ’24, another insider, Lin Patrick, who serves as the Chief Business – Strategy Off of the company, bought 2,500 shares for $2.37 each. As a result, the insider paid 5,925 and bolstered with 25,978 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PCSA now has a Market Capitalization of 2822962 and an Enterprise Value of 28346.
Stock Price History:
The Beta on a monthly basis for PCSA is 0.57, which has changed by -0.85 over the last 52 weeks, in comparison to a change of 0.23806548 over the same period for the S&P500. Over the past 52 weeks, PCSA has reached a high of $7.14, while it has fallen to a 52-week low of $0.81. The 50-Day Moving Average of the stock is -17.05%, while the 200-Day Moving Average is calculated to be -44.29%.
Shares Statistics:
PCSA traded an average of 323.77K shares per day over the past three months and 75950 shares per day over the past ten days. A total of 3.70M shares are outstanding, with a floating share count of 3.28M. Insiders hold about 11.34% of the company’s shares, while institutions hold 1.31% stake in the company. Shares short for PCSA as of 1734048000 were 333242 with a Short Ratio of 1.03, compared to 1731628800 on 73056. Therefore, it implies a Short% of Shares Outstanding of 333242 and a Short% of Float of 11.17.
Earnings Estimates
As of right now, 1.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.77, with high estimates of -$0.77 and low estimates of -$0.77.
Analysts are recommending an EPS of between -$4.05 and -$4.05 for the fiscal current year, implying an average EPS of -$4.05. EPS for the following year is -$2.16, with 1.0 analysts recommending between -$2.16 and -$2.16.
